NCJ Number
252583
Journal
Justice Evaluation Journal Volume: 1 Issue: 2 Dated: 2018 Pages: 151-187
Date Published
January 2019
Length
37 pages
Annotation
This article highlights key milestones, distinctive features, and the changing landscape of justice research over the past 50 years, reviewing the distinctive role that federal science agencies have had in determining what works and in advancing evidence-based approaches to crime and justice.
Abstract
Since the 1960s, research on crime, delinquency, and justice has achieved significant milestones in program evaluation. Advances have been made in identifying and cataloging evidence-based programs, practices, and policies for juvenile and criminal justice. These efforts have assisted in refining the definition of "evidence-based programs." This review extends the examination of current federal efforts to set future directions for evaluation and evidence-based work in the criminal justice field. It suggests important directions for the future, including the importance of program context, the trade-offs between implementation fidelity and experimentation, and the added value of supporting programs with decision-making tools and platforms. The article concludes with some insights about how current approaches to program evaluation may further evolve and expand, especially in the areas of program implementation, adaptation, and support for local capacity. The outcome should be a deeper understanding of the potential and the limitations of evaluation evidence in determining what does and does not work in achieving the goals of juvenile and criminal justice. (Publisher abstract modified)
Date Published: January 1, 2019
Downloads
Similar Publications
- Childhood Maltreatment and Biological Aging in Middle Adulthood: The Role of Psychiatric Symptoms
- "Suffering in Deafening Silence": Suicide Ideation and Attempted Suicide in the Lives of Incarcerated Rural West Virginia Girls
- Aiding or Enabling? Officer Perspectives on Harm Reduction and Support Services in an Open-air Drug Market